{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:10:09Z","timestamp":1758982209866,"version":"3.44.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018809","name":"Universidade Federal de Pelotas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.molimm.2023.01.007","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T19:03:02Z","timestamp":1675191782000},"page":"69-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Immunogenicity of an inactivated vaccine for intravaginal application against bovine alphaherpesvirus type 5 (BoHV-5)"],"prefix":"10.1016","volume":"155","author":[{"given":"Cristina Mendes","family":"Peter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lariane","family":"da Silva Barcelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos Roberto Alves","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie Bressan","family":"Waller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matheus Iuri","family":"Fr\u00fchauf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nad\u00e1lin Yandra","family":"Botton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabricio Rochedo","family":"Concei\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"de Oliveira H\u00fcbner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mario","family":"Barichello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3521-395X","authenticated-orcid":false,"given":"Geferson","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2023.01.007_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciimmunol.aat1482","article-title":"Revisiting IL-2: biology and therapeutic prospects","volume":"3","author":"Abbas","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.molimm.2023.01.007_bib2","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.4049\/jimmunol.162.4.2432","article-title":"Adjuvanticity of the cholera toxin A1-based gene protein, CTA1-DD, is critically dependent on the ADP-ribosyl transferase and Ig-binding activity","volume":"162","author":"Agren","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2023.01.007_bib3","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1128\/iai.61.11.4919-4924.1993","article-title":"Effect of cholera toxin on vaccine-induced immunity and infection in murine schistosomiasis mansoni","volume":"61","author":"Akhiani","year":"1993","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.molimm.2023.01.007_bib4","doi-asserted-by":"crossref","DOI":"10.3109\/21691401.2016.1146735","article-title":"Development of an effective delivery system for intranasal immunization against Mycobacterium tuberculosis ESAT-6 antigen","volume":"45","author":"Amini","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.molimm.2023.01.007_bib5","first-page":"28","article-title":"Mucosal HIV vaccines: a holy grail or a dud?","author":"Azizi","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2023.01.007_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF01315592","article-title":"Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production","volume":"1975","author":"Bahnemann","year":"1975","journal-title":"Arch. Virol."},{"issue":"7","key":"10.1016\/j.molimm.2023.01.007_bib7","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1128\/iai.65.7.2676-2684.1997","article-title":"Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina","volume":"65","author":"Bergquist","year":"1997","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.molimm.2023.01.007_bib8","doi-asserted-by":"crossref","DOI":"10.33448\/rsd-v11i5.28739","article-title":"A infec\u00e7\u00e3o pelos Alphaherpesvirus bovinos 1 e 5 e a indu\u00e7\u00e3o de imunidade de mucosa","volume":"11","author":"Botton","year":"2022","journal-title":"Res., Soc. Dev."},{"key":"10.1016\/j.molimm.2023.01.007_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4049\/jimmunol.1601775","article-title":"Inducing mucosal IgA: a challenge for vaccine adjuvants and delivery systems","volume":"199","author":"Boyaka","year":"2017","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.molimm.2023.01.007_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.vetmic.2010.08.004","article-title":"Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine","volume":"148","author":"Campos","year":"2011","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.molimm.2023.01.007_bib11","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1016\/j.vaccine.2006.04.036","article-title":"A recombinant chimera composed of R1 repeat region of Mycoplasma hyopneumoniae P97 adhesin with Escherichia coli heat-labile enterotoxin B subunit elicits immune response in mice","volume":"24","author":"Concei\u00e7\u00e3o","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.molimm.2023.01.007_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adhm.201801180","article-title":"Microneedle mediated vaccine delivery to the oral mucosa","volume":"8","author":"Creighton","year":"2019","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.molimm.2023.01.007_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s11250-019-02042-6","article-title":"Molecular and antigenic characterization of bovine herpesvirus type 1 (BoHV-1) strains from cattle with diverse clinical cases in Turkey","volume":"52","author":"Dagalp","year":"2020","journal-title":"Trop. Anim. Health Pro"},{"key":"10.1016\/j.molimm.2023.01.007_bib14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1365-2567.1998.00535.x","article-title":"Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit","volume":"94","author":"De Haan","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2023.01.007_bib15","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/S0264-410X(00)00556-9","article-title":"Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity","volume":"19","author":"De Haan","year":"2001","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.molimm.2023.01.007_bib16","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s11095-006-9104-4","article-title":"A review of poloxamer 407 pharmaceutical and pharmacological characteristics","volume":"23","author":"Dumortier","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.molimm.2023.01.007_bib17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11274-009-0195-z","article-title":"Recombinant Escherichia coli heat-labile enterotoxin B subunit humoral adjuvant effect depends on dose and administration route","volume":"26","author":"Fischer","year":"2010","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.molimm.2023.01.007_bib18","unstructured":"Fischer, G., Peter, C.M., Botton, N.Y., Barichello, J.M., Concei\u00e7\u00e3o, F.S., Barcelos, L.S., Ribeiro, L.C., Dominguez, J.H., Rodrigues, P.R.C., Ferreira, M.R.A., Vargas, G.D., de Lima, M., H\u00fcbner, S.O., Fr\u00fchauf, M.I., 2021. Patent number BR 1020210201282. Composi\u00e7\u00e3o de vacina intravaginal e vacina intravaginal inativada contra o Alphaherpesvirus bovino tipo 5. INPI deposition 2021."},{"issue":"16","key":"10.1016\/j.molimm.2023.01.007_bib19","article-title":"Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B, of herpes simplex virus","volume":"13","author":"Gallichan","year":"1995","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.molimm.2023.01.007_bib20","first-page":"545","article-title":"Mucosal immunity and vacines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2023.01.007_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biomaterials.2017.03.007","article-title":"Engineering intravaginal vaccines to overcome mucosal and epithelial barriers","volume":"128","author":"Ji","year":"2017","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.molimm.2023.01.007_bib22","first-page":"1","article-title":"Optimized mucosal modified vaccinia virus ankara prime\/soluble gp120 boost HIV vaccination regimen induces antibody responses similar to those of an intramuscular regimen","volume":"93","author":"Jones","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.molimm.2023.01.007_bib23","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/asj.12485","article-title":"Reference ranges of hematology and lymphocyte subsets in healthy Korean native cattle (Hanwoo) and Holstein dairy cattle","volume":"87","author":"Kim","year":"2016","journal-title":"Anim. Sci. J."},{"key":"10.1016\/j.molimm.2023.01.007_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/vetrec.165.4.111","article-title":"Infertility and venereal disease in cattle inseminated with semen containing bovine herpesvirus type 5","volume":"165","author":"Kirklland","year":"2009","journal-title":"Vet. Rec."},{"key":"10.1016\/j.molimm.2023.01.007_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2014.03.018","article-title":"Polymeric penetration enhancers promote humoral immune responses to mucosal vaccines","author":"Klein","year":"2014","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.molimm.2023.01.007_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2017.03.090","article-title":"Intranasal and sublingual delivery of inactivated polio vaccine","volume":"35","author":"Kraan","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2023.01.007_bib27","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-immunol-051116-052424","article-title":"Mucosal ecological network of epithelium and immune cells for gut homeostasis and tissue healing","volume":"35","author":"Kurashima","year":"2017","journal-title":"Annu Rev. Immunol."},{"issue":"5","key":"10.1016\/j.molimm.2023.01.007_bib28","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.fm.2011.01.011","article-title":"Effective hepatitis A virus inactivation during low-heat dehydration of contaminated green onions","volume":"28","author":"Laird","year":"2011","journal-title":"Food Microbiol"},{"key":"10.1016\/j.molimm.2023.01.007_bib29","doi-asserted-by":"crossref","unstructured":"Leite, F., Atapattu, D., Kuckleburg, C., Schultz, R., Czuprynski, C.J., 2005. Incubation of bovine PMNs with conditioned medium from BoHV-1 infected peripheral blood mononuclear cells increases their susceptibility to Mannheimia haemolytica leukotoxin. Vet. Immunol. Immunopathol. 130, 187\u201393.","DOI":"10.1016\/j.vetimm.2004.08.015"},{"issue":"60","key":"10.1016\/j.molimm.2023.01.007_bib30","first-page":"1","article-title":"Intranasal delivery of plasmids expressing bovine herpesvirus 1 gB\/gC\/gD proteins by polyethyleneimine magnetic beads activates long-term immune responses in mice","volume":"18","author":"Liu","year":"2021","journal-title":"Virol. J."},{"issue":"8","key":"10.1016\/j.molimm.2023.01.007_bib31","first-page":"1","article-title":"Characterization of BoHV-5 field strains circulation and report of transient specific subtype of bovine herpesvirus 5 in Argentina","volume":"7","author":"Maidana","year":"2011","journal-title":"BMC Vet. Res."},{"issue":"253","key":"10.1016\/j.molimm.2023.01.007_bib32","first-page":"1","article-title":"Characterization of BoHV-1 gG-\/tk-\/gE- mutant in differential protein expression","volume":"8","author":"Marawan","year":"2021","journal-title":"Virulence, Immun."},{"key":"10.1016\/j.molimm.2023.01.007_bib33","series-title":"Stutgart","first-page":"1982","article-title":"Virologische Arbeitsmethoden - Band IV - Sicherheit bei virologischen arbeiten - Biometrische Methoden","author":"Mayr","year":"1982"},{"key":"10.1016\/j.molimm.2023.01.007_bib34","first-page":"1","article-title":"Percutaneous vaccination as an effective method of delivery of MVA and MVA vectored vaccines","volume":"19","author":"Meseda","year":"2016","journal-title":"Plos One"},{"key":"10.1016\/j.molimm.2023.01.007_bib35","first-page":"1","article-title":"CD4 TRM cells following infection and immunization: implications for more effective vaccine design","author":"Mills","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.molimm.2023.01.007_bib36","first-page":"109","article-title":"Immune response of heifers to vaginal submucosal or subcutaneous vaccination and intravaginal challenge with ureaplasma diversum","volume":"58","author":"Mulira","year":"1994","journal-title":"Can. J. Vet. Res"},{"key":"10.1016\/j.molimm.2023.01.007_bib37","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2023.01.007_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prevetmed.2017.01.005","article-title":"Prevention of abortion in cattle following vaccination against bovine herpesvirus 1: A meta-analysis","volume":"138","author":"Newcomer","year":"2017","journal-title":"Prev. Vet. Med."},{"key":"10.1016\/j.molimm.2023.01.007_bib39","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.theriogenology.2010.11.025","article-title":"Detection of bovine herpesvirus 1 and 5 in semen from Brazilian bulls","volume":"75","author":"Oliveira","year":"2011","journal-title":"Theriogenology"},{"key":"10.1016\/j.molimm.2023.01.007_bib40","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/bs.vh.2021.06.005","article-title":"Regulation of neurotropic herpesvirus productive infection and latency-reactivation cycle by glucocorticoid receptor and stress induced transcription factors","volume":"117","author":"Ostler","year":"2021","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.molimm.2023.01.007_bib41","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1046\/j.1365-2567.1999.00909.x","article-title":"Immune responses and protection against vaginal infection after nasal or vaginal immunization with attenuated herpes simplex virus type-2","volume":"98","author":"Parr","year":"1999","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2023.01.007_bib42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1128\/JVI.00839-18","article-title":"Bovine Herpesvirus 1 Entry by a Low-pH Endosomal Pathway","volume":"92","author":"Pastenkos","year":"2018","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.molimm.2023.01.007_bib43","doi-asserted-by":"crossref","DOI":"10.33448\/rsd-v10i7.16732","article-title":"Desenvolvimento e uso de vacinas mucosas: potencial e limita\u00e7\u00f5es","volume":"10","author":"Peter","year":"2021","journal-title":"Res., Soc. Dev."},{"key":"10.1016\/j.molimm.2023.01.007_bib44","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.vaccine.2005.08.052","article-title":"Heat labile enterotoxin of E. coli: a potential adjuvant for transcutaneous cancer immunotherapy","volume":"24","author":"Pitcovski","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2023.01.007_bib45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.prevetmed.2010.06.001","article-title":"Seroepidemiology of bovine herpesvirus 1 (BHV1) infection among Estonian dairy herds and risk factors for the spread within herds","volume":"96","author":"Raaperi","year":"2010","journal-title":"Prev. Vet. Med."},{"key":"10.1016\/j.molimm.2023.01.007_bib46","first-page":"432","article-title":"The family Herpesviridae: An update","volume":"123","author":"Roizman","year":"1992","journal-title":"Arch. Virol."},{"key":"10.1016\/j.molimm.2023.01.007_bib47","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/wnan.131","article-title":"Topical and mucosal liposomes for vaccine delivery","volume":"3","author":"Romero","year":"2011","journal-title":"Wiley Inter. Rev. Nanomed. Nanobiotechnol"},{"issue":"8","key":"10.1016\/j.molimm.2023.01.007_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0104824","article-title":"Intranasal delivery of influenza rNP adjuvanted with cdi- AMP induces strong humoral and cellular immune responses and provides protection against virus challenge","volume":"9","author":"Sanchez","year":"2014","journal-title":"Plos One"},{"key":"10.1016\/j.molimm.2023.01.007_bib49","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/jbm.820060609","article-title":"Artificial skin I. Preparation and properties of pluronic F-127 gels for treatment of burn","volume":"6","author":"Schmolka","year":"1972","journal-title":"J. Biomed. Mater. Res."},{"issue":"2","key":"10.1016\/j.molimm.2023.01.007_bib50","first-page":"115","article-title":"Helicobacter pylori vaccine: mucosal adjuvant & delivery systems","volume":"130","author":"Sijun","year":"2009","journal-title":"Indian J. Med Res"},{"key":"10.1016\/j.molimm.2023.01.007_bib51","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1365-3083.2001.00884.x","article-title":"Immunomodulation using bacterial enterotoxins","volume":"53","author":"Simmons","year":"2001","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.molimm.2023.01.007_bib52","doi-asserted-by":"crossref","unstructured":"Sterlin, D., Mathian, A., Miyara, M., Mohr, A., Anna, F., Cla\u00ebr, L., Quentric, P., Fadllalah, J., Devilliers, H., Guillani, P., Gunn, C., Hockett, R., Madumba, S., Guihot, A., Luyt, C.-E., Mayaux, J., Beurton, A., Fourat, S., Bruel. T., Shwartz, O., Lacorte, J.-M., Yssel, H., Parizot, C., Dorgham, C., Charneau, P., Amoura, Z., Gorochov, G., 2021. IgA dominates the early neutralizing antibody response to SARS-CoV-2. Science translational medicine. 13(577): eabd2223.","DOI":"10.1126\/scitranslmed.abd2223"},{"issue":"494","key":"10.1016\/j.molimm.2023.01.007_bib53","article-title":"A comparison of intramuscular and subcutaneous administration of liga subunit vaccine adjuvanted with neutral liposomal formulation containing monophosphoryl lipid A and QS21","volume":"8","author":"Techawiwattanaboon","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.molimm.2023.01.007_bib54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.micpath.2015.08.013","article-title":"B subunits of cholera toxin and thermolabile enterotoxin of Escherichia coli have similar adjuvant effect as whole molecules on rotavirus 2\/6- VLP specific antibody responses and induce a Th17-like response after intrarectal immunization","volume":"89","author":"Thiam","year":"2015","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.molimm.2023.01.007_bib55","series-title":"Veterinaria","article-title":"Imunologia","author":"Tizard","year":"2019"},{"key":"10.1016\/j.molimm.2023.01.007_bib56","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0264-410X(97)00194-1","article-title":"Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin","volume":"16","author":"Tochikubo","year":"1998","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.molimm.2023.01.007_bib57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1590\/S0104-14282010005000009","article-title":"Aplica\u00e7\u00f5es Farmac\u00eauticas de Pol\u00edmeros","volume":"20","author":"Villanova","year":"2010","journal-title":"Pol\u00edmeros: Ci\u00eancia e Tecnologia"},{"issue":"5","key":"10.1016\/j.molimm.2023.01.007_bib58","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1128\/IAI.68.5.2775-2782.2000","article-title":"Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection","volume":"68","author":"Weltzin","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2023.01.007_bib59","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1016\/j.vaccine.2005.12.054","article-title":"Enhanced mucosal immunogenicity of prion protein following fusion with B subunit of Escherichia coli heat-labile enterotoxin","volume":"24","author":"Yamanaka","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2023.01.007_bib60","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tvjl.2009.03.035","article-title":"Biology of bovine herpesvirus 5","volume":"184","author":"Zajac","year":"2010","journal-title":"Vet. J."},{"issue":"1","key":"10.1016\/j.molimm.2023.01.007_bib61","first-page":"1","article-title":"Induction of both local immune response in mice and protection in a rabbit model by intranasal immunization with modified vaccinia ankara virus expressing a secreted form of bovine Herpesvirus 1 Glycoprotein D","volume":"30","author":"Zajac","year":"2017","journal-title":"Viral Immunol."},{"issue":"10","key":"10.1016\/j.molimm.2023.01.007_bib62","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2017.03.015","article-title":"Formulation of hydrophobic peptides for skin delivery via coated microneedles","volume":"265","author":"Zhao","year":"2017","journal-title":"J. Control Release"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589023000172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589023000172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:44:48Z","timestamp":1758980688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589023000172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":62,"alternative-id":["S0161589023000172"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2023.01.007","relation":{},"ISSN":["0161-5890"],"issn-type":[{"type":"print","value":"0161-5890"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity of an inactivated vaccine for intravaginal application against bovine alphaherpesvirus type 5 (BoHV-5)","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2023.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}